In April 2021, YiJiaLaoXiao reached a strategic cooperation with Shanghai Huimei Medical to officially launch the hydrogen oxygen medical project; during the same period, YiJiaLaoXiao strategically invested in Huimei Medical to become the national agent of its hydrogen oxygen products. Both parties will give full play to their resource advantages and two-way empowerment to create a model of close integration of innovative medical products and medical equipment supply chain channels, YiJiaLaoXiao will focus its resources through the free e-commerce platform and terminal medical equipment stores to help Shanghai Huimei complete the construction of the channel and sales, accelerate the layout of the national medical equipment channels and set up a full-scenario channel solution!

Huimei`s Introduction to Hydrogen Oxygen Machine

Chemical reduction: After entering the cell and malignant free radicals (-OH, ONOO-) combined to provide safe and effective anti-inflammatory, antioxidant pathway to relieve inflammation, can enhance the mitochondria (mitochondria) ability to produce cellular energy ATP.

Physical effects: the use of hydrogen molecules 10-10 tiny molecules to help oxygen diffusion, improve the state of low blood oxygen original water shock atomization function, to help the liquid small molecules into the cells after absorption, to enhance the efficacy of the drug.

From the world's latest patented technology to check the new verification, its safe design, zero air cavity, multiple explosion-proof, multi-layer bacterial filtration, long-time operation, concentration of intelligent control, twenty-four physiological indicators to detect the wearable bracelet with the advantages, in line with the volume of the smallest, the largest gas production, the human body is safe, the treatment effect of good respiratory therapy equipment.

In March, 2017, Huimei`s the Hydrogen Oxygen Nebulizer was approved to enter the "National Innovation" Class III medical device green channel.

In February 2020, Huimei`s the Hydrogen Oxygen Nebulizer obtained the registration certificate of Class III medical device of the People's Republic of China.

In March 2020, it was included in the seventh edition of the national treatment program for new coronary pneumonia as the only legal clinical application device.